Feltri Pietro, Solaro Luca, Errani Costantino, Schiavon Guglielmo, Candrian Christian, Filardo Giuseppe
Orthopaedic and Traumatology Unit, Ospedale Regionale di Lugano, EOC, 6900, Lugano, Switzerland.
Clinica Ortopedica e Traumatologica II, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli, 1/10, 40136, Bologna, Italy.
Arch Orthop Trauma Surg. 2023 Jan;143(1):29-48. doi: 10.1007/s00402-021-03962-5. Epub 2021 Jun 10.
To quantify union rate, complication rate, reintervention rate, as well as functional outcome after vascularized fibular bone grafts (VFGs) for the treatment of long-bone defects.
A comprehensive search was performed in the PubMed, Web of Science, and Cochrane databases up to August 18, 2020. Randomized controlled trials, comparative studies, and case series describing the various techniques available involving VFGs for the reconstruction of segmental long-bone defects were included. A meta-analysis was performed on union results, complications, and reinterventions. Assessment of risk of bias and quality of evidence was performed with the Downs and Black's "Checklist for Measuring Quality".
After full-text assessment, 110 articles on 2226 patients were included. Among the retrieved studies, 4 were classified as poor, 83 as fair, and 23 as good. Overall, good functional results were documented and a union rate of 80.1% (CI 74.1-86.2%) was found, with a 39.4% (CI 34.4-44.4%) complication rate, the most common being fractures, non-unions and delayed unions, infections, and thrombosis. Donor site morbidity represented 10.7% of the total complications. A 24.6% reintervention rate was documented (CI 21.0-28.1%), and 2.8% of the patients underwent amputation.
This systematic review and meta-analysis documented good long-term outcomes both in the upper and lower limb. However, VFG is a complex and demanding technique; this complexity means an average high number of complications, especially fractures, non-unions, and vascular problems. Both potential and limitations of VFG should be considered when choosing the most suitable approach for the treatment of long-bone defects.
量化血管化腓骨移植(VFG)治疗长骨缺损后的愈合率、并发症发生率、再次干预率以及功能结局。
截至2020年8月18日,在PubMed、科学网和Cochrane数据库中进行了全面检索。纳入了随机对照试验、比较研究以及描述涉及VFG重建节段性长骨缺损的各种可用技术的病例系列。对愈合结果、并发症和再次干预进行了荟萃分析。使用唐斯和布莱克的“质量测量清单”对偏倚风险和证据质量进行评估。
经过全文评估,纳入了110篇关于2226例患者的文章。在检索到的研究中,4篇被归类为质量差,83篇为质量一般,23篇为质量好。总体而言,记录了良好的功能结果,发现愈合率为80.1%(95%CI 74.1 - 86.2%),并发症发生率为39.4%(95%CI 34.4 - 44.4%),最常见的是骨折、骨不连和延迟愈合、感染以及血栓形成。供区并发症占总并发症的10.7%。记录的再次干预率为24.6%(95%CI 21.0 - 28.1%),2.8%的患者接受了截肢。
本系统评价和荟萃分析记录了上肢和下肢均有良好的长期结局。然而,VFG是一种复杂且要求较高的技术;这种复杂性意味着平均并发症数量较高,尤其是骨折、骨不连和血管问题。在选择治疗长骨缺损的最合适方法时,应考虑VFG的潜力和局限性。